• Provides payer perspective to inform early-phase R&D decisions
• Uses decision criteria that reimbursement authorities and third-party payers most often apply
• Can be used to rank a new product’s reimbursement profile versus comparator agents
• Enables sensitivity analysis of attributes in a new product’s profile

The Reimbursement Index estimates how conservative or liberal payer policies for a new agent are likely to be by placing it in a spectrum of launched agents that range from greater to lesser reimbursement friction.

Reimbursement Index Comparators